Location
Global
Company size
50000
Industry
Target
AbbVie commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by 2030 from its 2021 baseline year
AbbVie is a pharmaceutical company engaged in the research and development, manufacturing, commercialization, and sale of medicines and therapies. Its products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and HIV; neurological disorders, such as Parkinson’s disease; metabolic diseases; hormonal disorders; in pulmonology such as idiopathic pulmonary fibrosis and cystic fibrosis; and other health conditions. The company has more than 721,000 employees worldwide.
